Search - tctmd.com

Displaying 301 - 320 of 487

Sort: Relevancy | Date

News Conference News AHA 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Yael L. Maxwell

November 10, 2018

News Daily News

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Yael L. Maxwell

October 30, 2018

News Daily News

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

Yael L. Maxwell

September 10, 2018

News Daily News

‘Just Move’: Registry Study Shows Positive CV Effects of Light Physical Activity in Older Adults

Yael L. Maxwell

August 08, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

News Conference News SCCT 2018

Think Like a Patient: Rationale and Resources for Shared Decision-Making in Cardiology

Yael L. Maxwell

July 13, 2018

News Daily News

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

Yael L. Maxwell

July 09, 2018

News Daily News

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Yael L. Maxwell

June 29, 2018

News Daily News

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Yael L. Maxwell

June 25, 2018

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

News Daily News

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

Yael L. Maxwell

May 18, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

Heart Transplants From Overdose Deaths Are Soaring, With Promising Results

Yael L. Maxwell

April 17, 2018

Advertisement

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

‘Just Move’: Registry Study Shows Positive CV Effects of Light Physical Activity in Older Adults

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Think Like a Patient: Rationale and Resources for Shared Decision-Making in Cardiology

Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Clinical Benefit of Lowering Lp(a) Is Proportional to Its Absolute Reduction: Mendelian Randomization Analysis

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Hypertension During Pregnancy Linked With Subsequent A-fib in Women

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Heart Transplants From Overdose Deaths Are Soaring, With Promising Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content